Leukemia research

Leuk Res · ISSN (print) 0145-2126 · 3 papers in corpus
nonrandomized-trial 2017
Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis
doi:10.1016/j.leukres.2017.06.005 ·PMID:28646676

Myelofibrosis is a myeloproliferative neoplasm that is characterized by splenomegaly, profound symptom burden, and cytopenias. JAK inhibitor therapy offers improvements in splenomegaly, symptom burden, and potentially survival; however, cyt…

nonrandomized-trial 2006
Successful treatment of primary refractory anemia with a combination regimen of all-trans retinoic acid, calcitriol, and androgen
doi:10.1016/j.leukres.2005.11.017 ·PMID:16445979

We investigated the efficacy and safety of a combination regimen in 63 patients with primary refractory anemia (RA). The daily treatment protocol comprised all-trans retinoic acid (ATRA) (30 mg/m(2)), calcitriol (0.1 microg/m(2)), and andro…

lab-animal 1993
Constitutive production of interleukin-8 (IL-8) by normal and malignant human B-cells and other cell types
doi:10.1016/0145-2126(93)90164-g ·PMID:8246610

The culture supernatants from 43 human cell lines obtained during log phase and from purified normal peripheral blood B-lymphocytes cultured at 10(6) cells ml-1 for 48 h in RPMI 1640-5% fetal calf serum were examined for interleukin-8 (IL-8…